2010
DOI: 10.4049/jimmunol.1000789
|View full text |Cite
|
Sign up to set email alerts
|

Intracellular Sequestration of the NKG2D Ligand ULBP3 by Human Cytomegalovirus

Abstract: Human CMV (HCMV) encodes multiple genes that control NK cell activation and cytotoxicity. Some of these HCMV-encoded gene products modulate NK cell activity as ligands expressed at the cell surface that engage inhibitory NK cell receptors, whereas others prevent the infected cell from upregulating ligands that bind to activating NK cell receptors. A major activating NKR is the homodimeric NKG2D receptor, which has eight distinct natural ligands in humans. It was shown that HCMV is able to prevent the surface e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
42
0
1

Year Published

2011
2011
2018
2018

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 67 publications
(44 citation statements)
references
References 71 publications
1
42
0
1
Order By: Relevance
“…However, the evidence that in primary fibroblasts MICA was induced by both laboratory and low-passage HCMV strains suggests that the downmodulating activity exerted by the viral proteins UL142, US9, US18, and US20 on this ligand (14-17) was not sufficient to prevent its overall cell surface expression. Similarly, although UL142 was described to prevent expression of ULBP3 as well (67), in our settings this ligand was always increased, consistent with previous findings (57). These discrepancies may be related to different experimental conditions and/or to the considerable polymorphism in the UL142 sequence among different strains (68,69).…”
Section: Discussionsupporting
confidence: 79%
“…However, the evidence that in primary fibroblasts MICA was induced by both laboratory and low-passage HCMV strains suggests that the downmodulating activity exerted by the viral proteins UL142, US9, US18, and US20 on this ligand (14-17) was not sufficient to prevent its overall cell surface expression. Similarly, although UL142 was described to prevent expression of ULBP3 as well (67), in our settings this ligand was always increased, consistent with previous findings (57). These discrepancies may be related to different experimental conditions and/or to the considerable polymorphism in the UL142 sequence among different strains (68,69).…”
Section: Discussionsupporting
confidence: 79%
“…Interestingly, all OWM CMVs lack several known HCMV antagonists of NK cell function, including UL16, which retains the NKG2D ligands MICB, ULBP1, and ULBP2 (22,77), UL141, which retains the NKG2D ligands MICA and ULBP3 (4,8,11), and UL18, which encodes an MHC-I homologue that binds to the inhibitory NK cell receptor LIR-1 (16,56,62). Since evasion of NK cell immunity is conserved in MCMV (6), it is likely that OWM CMV-specific genes will encode NK cell evasins.…”
Section: Resultsmentioning
confidence: 99%
“…Compared with the genome of the prototype laboratory strain, AD169, genomes of low-passage HCMV clinical isolates contain the UL/b' region, including ORFs UL133-UL151, considered as a critical candidate cluster to clinical pathogenesis (3). Although the UL/b' region is not essential to viral growth or replication (4), products of this region, including UL141, UL142 and UL144 have been experimentally identified to aid in viral escape from immune surveillance through interactions with cellular molecules (5)(6)(7)(8)(9)(10).…”
Section: Introductionmentioning
confidence: 99%